| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.095 | 0.03 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.61 | 0.03 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.32 | 0.04 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.29 | 0.04 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.04 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.065 | 0.04 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |